Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Ajaz Hussain and Wuxi Apptec’s Dr Minzhang Chen join 12 strong CPhI Annual Industry report experts

CPhI
Posted on: 06 Sep 16

2016 report topics include 3D printing, FDA quality metrics, contract services, pharma growth in China and India, and generic licensing

 

The CPhI Expert Panel members for 2016 are:

  • Gil Roth, President at PBOA
  • Alan Sheppard, Principal, Global Generics at IMS Health
  • Vivek Sharma, CEO at Piramal Enterprises Ltd.
  • Ajaz Hussain, Founder CEO at Insight Advice & Solutions LLC
  • Dr Minzhang Chen, CEO at STA Pharma (Wuxi Apptec)
  • Dilip Shah, CEO at Vision Consulting Group
  • Prabir Basu, Pharma Manufacturing and Regulations Consultant
  • Brian Carlin, Director Open Innovation at FMC
  • Emil Cuirczak, President at Doramaxx Consulting
  • Bikash Chatterjee, President and CSO at PharmTech Associates
  • Girish Malhotra, President at EPCOT International
  • Ravi Limaye, President, Marketing at Biocon

 

Amsterdam, 06 September 2016: CPhI Worldwide, organized by UBM EMEA, announces the 2016 expert panel for the eagerly awaited CPhI Worldwide Annual Industry Report (4th edition) – to be released September and October 2016, in three parts. The report is a comprehensive and critically important publication that analyses key trends and innovations forecast by a panel of world class experts. Running as a series of opinions and articles, the CPhI experts call upon their collective 200+ years of commercial and technical acumen to prophesise the future direction, technologies, opportunities and threats in pharma. It’s an essential read for executives who wish to get a head start today on the shape of tomorrow’s industry.

This year, the CPhI Annual Report will see ten experts returning from 2015, along with two new valuable additions: Ajaz Hussain, Founder and CEO at Insight Advice & Solutions LLC (also the current president of NIPTE) and Dr Minzhang Chen, CEO of STA Pharmaceuticals – the API development and manufacturing division of Wuxi Apptec.

Dr Minzhang Chen is known globally in the pharmaceutical and biopharmaceutical industry and has over 18 years of experience in Process R&D and API Manufacturing. STA pharmaceutical is the leading China based CDMO and is a standard bearer of emerging research in China and globally.

Ajaz Hussain is a widely recognized leader within pharmaceuticals and drug development, having previously worked at the FDA, Wockhardt and Sandoz. He is an internationally renowned thought leader on pharmaceutical manufacturing, research and harmonisation – he served as the FDAs ICH lead, expediting the progress and implementation of ICH Q8, Q9 and Q10.

The 2016 report will provide an overview of contract services growth, predictions on continuous processing and 3D printing of finished formulations. Brian Carlin of FMC will look at the role of excipients, whilst Prabir Basu will explore new types of FDA quality metrics. Generics are also a central part of two expert contributions – from Alan Sheppard and Dilip Shah – with overall growth and licensing trends analysed. Additionally, Bikash Chatterjee will explain the how the management of data and information in pharma will be key to defining the industry in the next decade.

The Chinese and Indian global pharma economies continue to drive growth, and representatives from Piramal, Biocon and Wuxi Apptec will examine factors affecting the markets in the next 2-5 years.

This year’s annual report features over 200+years of high level pharma expertise providing unparalleled insights into global trends, issues and challenges over the short and medium term. The panel provides a balanced view of experts from independent consultants and representatives from all the major pharma economies.

As the pharma industry continues to globalise and new technologies emerge, access to information on how to implement new methods and development will become increasingly business critical to both pharma and supply side companies. Our annual report is released to help the industry stay informed, to stimulate debate and collaborations, and more quickly develop the pharmaceutical products of tomorrow”, commented Chris Kilbee, Group Director Pharma at UBM EMEA.

The CPhI 2016 Annual Report is available for download, along with other Pharma Insights Reports, at: http://www.cphi.com/europe/pharma-insights-reports-cphi-worldwide

 

-ENDS-

 

Notes to editors

 

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul and Russia, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

 

For more information visit: www.cphi.com

 

The UBM EMEA annual schedule of Pharmaceutical events includes: CPhI, ICSE, FDF, P-MEC and InnoPack Worldwide (4-6 October, 2016, Fira de Barcelona Gran Via, Barcelona, Spain); CPhI & P-MEC India (21-23 November, 2016, BEC and BKC Exhibition and Convention Centres, Mumbai, India), Pharmapack Europe (01-02 February, 2017); CPhI Istanbul (8-10 March, 2017 at the IFC Istanbul Expo Center, Istanbul, Turkey); CPhI, P-MEC and Innopack South East Asia (22-24 March, 2017 at the Jakarta International Expo- Jakarta, Indonesia); CPhI Russia (28 March – 30 March, 2017 at JSC VDNH (VVC), Pavilion 75, Hall A, Moscow); CPhI, ICSE, P-MEC, BioPh and InnoPack Japan (19-21 April, 2017 at the Big Sight Exhibition Centre- Tokyo); InformEx (16-18 May, 2017); CPhI China and P-MEC (20-22 June, 2017 at SNIEC, Shanghai, China); CPhI Korea (22-24 August, 2017, COEX Hall D, Seoul, Korea)

 

About UBM EMEA

UBM EMEA connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

 

For media enquiries, please contact:

Alex Heeley or Nadine Caillaux

De Facto Communications

T: +44 (0) 203 735 8168

 

E: a.heeley@defacto.com / n.caillaux@defacto.com

Editor's Details

Nadine Caillaux
De Facto Communications
www.defacto.com
02037358168
n.caillaux@defacto.com

Last updated on: 06/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.